Publikationen von R. Rupprecht

Baghai, T. C.; Binder, E. B.; Holsboer, F.; Rupprecht, R.; Bondy, B.: Polymorphisms in the angiotensin converting enzyme (ACE) gene are associated with unipolar depression, ACE activity and hypercortisolism. Pharmacopsychiatry 38 (5), S. 228 - 228 (2005)

Schüle, C.; Baghai, T. C.; Eser, D.; Schaaf, L.; Rupprecht, R.: The combined T3/TRH-test in depressed patients and healthy controls. Pharmacopsychiatry 38 (5), S. 277 - 277 (2005)

Schüle, C.; Baghai, T. C.; Tsikolata, V.; Zwanzger, P.; Eser, D.; Schaaf, L.; Rupprecht, R.: The combined T3/TRH test in depressed patients and healthy controls. Psychoneuroendocrinology 30 (4), S. 341 - 356 (2005)

Binder, E. B.; Salyakina, D.; Wochnik, G.; Ising, M.; Pütz, B.; Kern, N.; Lucae, S.; Mueller, J. C.; Lohmussaar, E.; Meitinger, T. et al.; Baghai, T.; Bondy, B.; Rupprecht, R.; Uhr, M.; Rein, T.; Holsboer, F.; Müller-Myhsok, B.: Polymorphisms in FKBP5, a co-chaperone of the glucocorticoid receptor are associated with response to antidepressant drugs. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 130B (1), S. 13 - 13 (2004)

Rammes, G.; Eisensamer, B.; Ferrari, U.; Shapa, M.; Gimpl, G.; Gilling, K.; Parsons, C.; Riering, K.; Hapfelmeier, G.; Bondy, B. et al.; Zieglgänsberger, W.; Holsboer, F.; Rupprecht, R.: Antipsychotic drugs antagonize human serotonin type 3 receptor currents in a noncompetitive manner. Molecular Psychiatry 9 (9), S. 846 - 858 (2004)

Zwanzger, P.; Eser, D.; Padberg, F.; Baghai, T. C.; Schule, C.; Rupprecht, R.; di Michele, F.; Romeo, E.; Pasini, A.; Ströhle, A.: Neuroactive steroids are not affected by panic induction with 50 mu g cholecystokinin-tetrapeptide (CCK-4) in healthy volunteers. Journal of Psychiatric Research 38 (2), S. 215 - 217 (2004)

Binder, E. B.; Salyakina, D.; Lichtner, P.; Wochnik, G. M.; Ising, M.; Pütz, B.; Papiol, S.; Seaman, S.; Lucae, S.; Kohli, M. et al.; Nickel, T.; Künzel, H.; Fuchs, B.; Majer, M.; Pfennig, A.; Kern, N.; Brunner, J.; Modell, S.; Baghai, T.; Deiml, T.; Zill, P.; Bondy, B.; Rupprecht, R.; Messer, T.; Köhnlein, O.; Dabitz, H.; Brückl, T.; Müller, N.; Pfister, H.; Lieb, R.; Mueller, J. C.; Löhmussaar, E.; Strom, T. M.; Bettecken, T.; Meitinger, T.; Uhr, M.; Rein, T.; Holsboer, F.; Müller-Myhsok, B.: Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nature Genetics 36, S. 1319 - 1325 (2004)

Deiml, T.; Haseneder, R.; Zieglgänsberger, W.; Rammes, G.; Eisensamer, B.; Rupprecht, R.; Hapfelmeier, G.: α-Thujone reduces 5-HT3 receptor activity by an effect on the anonist-induced desensitization. Neuropharmacology 46, S. 192 - 201 (2004)

Rammes, G.; Eisensamer, B.; Ferrari, U.; Shapa, M.; Gimpl, G.; Gilling, K.; Parsons, C.; Riering, K.; Hapfelmeier, G.; Bondy, B. et al.; Zieglgänsberger, W.; Holsboer, F.; Rupprecht, R.: Antipsychotic drugs antagonize human serotonin type 3 (5-HT₃) receptor currents in a noncompetitive manner [Image]. Molecular Psychiatry 9 (9), S. 818 - 818 (2004)

Deiml, T.; Haseneder, R.; Zieglgänsberger, W.; Baghai, T. C.; Eser, D.; Schule, C.; Ella, R.; Eisensamer, B.; Rupprecht, R.; Hapfelmeier, G.: alpha-thujone reduces 5-HT3 receptor activity by an effect on the agonist-induced desensitization. Pharmacopsychiatry 36 (5), S. 219 - 219 (2003)

Eisensamer, B.; Rammes, G.; Gimpl, G.; Shapa, M.; Ferrari, U.; Hapfelmeier, G.; Bondy, B.; Parsons, C.; Gilling, K.; Zieglgänsberger, W. et al.; Holsboer, F.; Rupprecht, R.: Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor. Pharmacopsychiatry 36 (5), S. 223 - 223 (2003)

Rupprecht, R.; Eisensamer, B.: Modulation of ligand-gated ion channels by antidepressants. Pharmacopsychiatry 36 (5), S. 258 - 258 (2003)

Rupprecht, R.; Lancel, M.; Friess, E.; Ströhle, A.; Holsboer, F.; Romeo, E.: GABAergic effects of neuroactive steroids: Modulation of sleep and anxiety. Pharmacopsychiatry 36 (5), S. 258 - 258 (2003)

Hapfelmeier, G.; Tredt, C.; Haseneder, R.; Zieglgänsberger, W.; Eisensamer, B.; Rupprecht, R.; Rammes, G.: Co-expression of the 5-HT3B serotonin receptor subunit alters the biophysics of the 5-HT3 receptor. Biophysical Journal 84 (3), S. 1720 - 1733 (2003)

Schüle, C.; di Michele, F.; Baghai, T.; Romeo, E.; Bernardi, G.; Zwanzger, P.; Padberg, F.; Pasini, A.; Rupprecht, R.: Influence of sleep deprivation major depression on neuroactive steroids in major depression. Neuropsychopharmacology 28 (3), S. 577 - 581 (2003)

Rupprecht, R.: Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties. Psychoneuroendocrinology 28 (2), S. 139 - 168 (2003)

Eisensamer, B.; Rammes, G.; Gimpl, G.; Shapa, M.; Ferrari, U.; Hapfelmeier, G.; Bondy, B.; Parsons, C.; Gilling, K.; Zieglgänsberger, W. et al.; Holsboer, F.; Rupprecht, R.: Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor. Molecular Psychiatry 8 (12), S. 994 - 1007 (2003)

Padberg, F.; Zinka, B.; Zwanzger, P.; Ella, R.; Rupprecht, R.; Keck, M. E.; Möller, H. J.: Präfrontale repetitive transkranielle Magnetstimulation in der Therapie depressiver Erkrankungen. Nervenheilkunde 22 (7), S. 331 - 340 (2003)

Damianisch, K.; Rupprecht, R.; Lancel, M.: The influence of subchronic administration of the neurosteroid allopregnanolone on sleep in the rat. Neuropsychopharmacology 25, S. 576 - 584 (2001)

Hermann, B.; Vollmer, I.; Holsboer, F.; Rupprecht, R.: Antidepressants do not modulate estrogen receptor α-mediated gene expression. Journal of Neural Transmission 108, S. 1197 - 1202 (2001)